Burning Rock Biotech Limited (BNR) Tops Q2 EPS by 9c

Burning Rock Biotech Limited (NASDAQ: BNR) reported Q2 EPS of (RMB1.28), RMB0.09 better than the analyst estimate of (RMB1.37). Revenue for the quarter came in at RMB146.3 million versus the consensus estimate of RMB173 million.

For earnings history and earnings-related data on Burning Rock Biotech Limited (BNR) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• BitFuFu Inc. (FUFU) Misses Q2 EPS by 13c
• Benchmark Reiterates Buy Rating on Odysight.AI Inc. (ODYS)